A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer

The IPTLD QoL Broad Study A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02598479

Acronym

IPTLDAZCAM

Enrollment

Registered

2015-11-06

Start date

2015-11-30

Completion date

2018-08-31

Last updated

2018-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancer, Insulin Potentiation Low Dose Chemotherapy, IPT, IPTLD, Nutrition therapy

Brief summary

The IPTLD QoL Broad Study.

Detailed description

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer.

Interventions

OTHERIPTLD and nutrition therapy

The measurement of Quality of Life in patients who choose to use Insulin Potentiation Low Dose Therapy and Nutritional Therapy in the treatment of cancer

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* diagnosis of cancer, * age older than 18 years, * requesting IPTLD and nutrition therapy

Exclusion criteria

* diagnosis other than cancer, * age younger than 18 years, * requesting conventional chemotherapy

Design outcomes

Primary

Measure	Time frame	Description
Improvement in Quality of Life measured by questionnaires	5 years	Improvement in Quality of Life using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy for the Treatment of Cancer, as measured by MD Anderson's MDASI questionnaires

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026